Following positive two-year human clinical data from its scaffold-guided regenerative program, BellaSeno has announced an exclusive global licensing agreement with Mentor Worldwide LLC, a Johnson & Johnson company.

This collaboration will bring together BellaSeno’s technology alongside the clinical, regulatory and commercial scale of one of the world’s leading healthcare companies. As breast aesthetics continues to evolve, there is growing demand for approaches that expand the range of solutions available to patients and surgeons. This collaboration will help accelerate the final clinical development of the breast scaffold platform as BellaSeno prepares for global market introduction.